Search clinical trials for: Cycloset

Total 127 results

KU Leuven

Enrolling by invitation

The Impact of Grand Tour Cycling on Sleep and the Hematological and Metabolomic Profile in World-class Cyclists

Overreaching

Belgium
Sun Pharmaceutical Industries Limited

Completed

Pharmacokinetic and Pharmacodynamic Study of Cyclofem

Contraception

United States
Iantrek, Inc.

Enrolling by invitation

Study of the CycloPen Micro-Interventional System and Long-Term Clinical Outcomes (CREST)

Open Angle Glaucoma

United States
Danish Headache Center

Completed

PACAP Induced Migraine Attacks in Patients With High and Low Genetic Load

Migraine Without Aura

Denmark
Song Guo

Completed

The Effect of Histamine H1 Receptor Antagonist, Clemastin, on PACAP38 Induced Headache in Migraine Patients

Migraine Without Aura

Denmark
Danish Headache Center

Recruiting

Hypersensitivity to PACAP-38 in Post-Traumatic Headache

Post-Traumatic Headache

Denmark
Danish Headache Center

Completed

The Hemodynamic Effects of PACAP38 After Glibenclamide Administration in Healthy Volunteers

Pain | Migraine | Headache

Denmark
Mohamed Sayed Abdelhafez

Completed

Vaginal Progesterone for Prevention of Preterm Labor in Asymptomatic Twin Pregnancies With Sonographic Short Cervix

Premature Labour

Egypt
Mỹ Đức Hospital

Completed

Progesterone Versus Progesterone Plus Dydrogesterone in FET (MiDRONE)

Infertility

Vietnam
Allergan
Ironwood Pharmaceuticals, Inc.

Completed

Linaclotide Safety and Efficacy in 2 to 5-Year-Old Participants With Functional Constipation

Functional Constipation

United States
Ironwood Pharmaceuticals, Inc.
Forest Laboratories

Completed

Trial of Linaclotide in Patients With Chronic Constipation

Chronic Constipation

United States
Eastern Virginia Medical School

Completed

Bromocriptine-QR Therapy on Sympathetic Tone and Vascular Biology in Type 2 Diabetes Subjects

Diabetic Autonomic Neuropathy

United States
Bausch Health Americas, Inc.
Syneos Health

Completed

Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)

Chronic Idiopathic Constipation

United States, Canada
Ironwood Pharmaceuticals, Inc.
Allergan Sales, LLC

Completed

A Trial of Linaclotide 290 μg in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

Irritable Bowel Syndrome Characterized by Constipation

United States
Bausch Health Americas, Inc.

Completed

A Postmarketing Study of Plecanatide in Breast Milk of Lactating Women Treated With TRULANCE®

Chronic Idiopathic Constipation

United States
Bausch Health Americas, Inc.

Completed

12-Week Study of Plecanatide for CIC (The National CIC3 Study) (CIC)

Chronic Idiopathic Constipation

United States
Astellas Pharma Inc

Completed

A Study of Oral Dosing of ASP0456 in Patients With Chronic Constipation

Chronic Constipation

Japan
Ironwood Pharmaceuticals, Inc.

Completed

Phase 2 Study of MD-1100 Acetate on Gastrointestinal Transit in Patients With C-IBS

Irritable Bowel Syndrome

United States
Vietnam National University
Mỹ Đức Hospital

Completed

Cervical Pessary vs. Vaginal Progesterone for Preventing Premature Birth in IVF Twin Pregnancies

Pregnancy

Vietnam
Mayo Clinic

Completed

Vaginal Bromocriptine for Treatment of Adenomyosis

Adenomyosis

United States
Astellas Pharma Inc

Completed

Phase III Study to Evaluate the Efficacy and Safety of ASP0456 in Patients With Constipation Predominant Irritable Bowel Syndrome

Irritable Bowel Syndrome With Constipation (IBS-C)

Japan
Ironwood Pharmaceuticals, Inc.
Forest Laboratories

Completed

An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation

Irritable Bowel Syndrome With Constipation | Chronic Constipation

United States
Ironwood Pharmaceuticals, Inc.

Completed

Randomized, Double-blind, Dose-range-finding, Phase 2 Study of Linaclotide Administered to Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

Irritable Bowel Syndrome With Constipation

United States, Canada
Ironwood Pharmaceuticals, Inc.

Completed

Phase 2 Study of MD-1100 Acetate Administered for 14 Days to Patients Meeting Criteria for Chronic Constipation

Constipation

United States
Ampio Pharmaceuticals. Inc.

Completed

A Safety and Efficacy Study of Oral Danazol (a Previously Approved Drug) in the Treatment of Diabetic Macular Edema.

Diabetic Macular Edema
IWK Health Centre

Unknown

Effect of Bromocriptine on Insulin Resistance in Polycystic Ovarian Syndrome - A Pilot Study (PCOS-Pilot)

Insulin Resistance | PCOS

Canada
Iowa State University
USDA Beltsville Human Nutrition Research Center

Completed

Effects of Black Bean Pasta Consumption on Biomarkers in Young Adults

Glucose, High Blood

United States
Bausch Health Americas, Inc.

Completed

Long Term Safety Study of Plecanatide (IBS-C)

Irritable Bowel Syndrome

United States
Bausch Health Americas, Inc.

Completed

Second Plecanatide Study In Irritable Bowel Syndrome With Constipation (IBS-C) (IBS-C)

Irritable Bowel Syndrome Characterized by Constipation

United States
Bausch Health Americas, Inc.

Completed

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C) (IBS-C)

Irritable Bowel Syndrome Characterized by Constipation

United States
Augusta University
Forest Laboratories

Completed

Investigation of Linaclotide's Effect on the Bi-directional Brain and Gut Axis in IBS-C Patients

Irritable Bowel Syndrome With Constipation (IBS-C)

United States
AstraZeneca
Ironwood Pharmaceuticals, Inc.

Completed

A Phase 3, International, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Efficacy and Safety Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Irritable Bowel Syndrome With Constipation (IBS-C) (D5630C00001)

Irritable Bowel Syndrome With Constipation (IBS-C)

United States, Australia, China, New Zealand, Canada
Glostrup University Hospital, Copenhagen
Bispebjerg Hospital; Lundbeck Foundation; University Hospital, Gentofte, Copenhagen and other collaborators

Completed

Effect of PACAP38/VIP on Migraineurs Measured by Magnetic Resonance

Migraine Without Aura

Denmark
Mohamed Sayed Abdelhafez

Recruiting

Vaginal Progesterone Versus Cervical Cerclage for Pregnant Women With Short Cervix and History of PTL and/or MTM

Premature Labour

Egypt
Ironwood Pharmaceuticals, Inc.
Manchester University NHS Foundation Trust

Terminated

A Study of the Effect of Linaclotide on Abdominal Girth in Participants With Irritable Bowel Syndrome With Constipation (IBS-C)

Irritable Bowel Syndrome Characterized by Constipation

United Kingdom
Forest Laboratories
Ironwood Pharmaceuticals, Inc.

Completed

An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation

Irritable Bowel Syndrome With Constipation | Chronic Constipation

United States, Canada
University of Virginia

Completed

Single-dose Linaclotide for Capsule Endoscopy Preparation

Ulcerative Colitis | Gastrointestinal Bleeding | Crohn's

United States
VeroScience

Completed

Safety and Tolerability Study of Cycloset in Treatment of Type 2 Diabetes

Type 2 Diabetes Mellitus
VeroScience

Terminated

Efficacy and Safety of Cycloset® Compared With Placebo When Added to Metformin

Type 2 Diabetes
Mayo Clinic
AbbVie; Cedars-Sinai Medical Center; Ironwood Pharmaceuticals, Inc.

Recruiting

A Study of Virtual Reality and Linaclotide for IBS-C (IBSC-VR)

Irritable Bowel Syndrome With Constipation

United States
Shandong Luoxin Pharmaceutical Group Stock Co.,...

Active, not recruiting

Efficacy and Safety of Plecanatide Comparing With Placebo in the Treatment of Functional Constipation

Functional Constipation

China
Jiangsu Hansoh Pharmaceutical Co., Ltd.

Unknown

Evaluation of Clinical Equivalence Between Two Linaclotide Products in the Treatment of Chronic Idiopathic Constipation

Chronic Idiopathic Constipation

China
Cyclerion Therapeutics

Completed

Trial of IW-1973, A Stimulator of Soluble Guanylate Cyclase (sGC) in Patients With Stable Type 2 Diabetes and Hypertension

Hypertension | Diabetes Mellitus, Type 2

United States
Forest Laboratories
Ironwood Pharmaceuticals, Inc.

Completed

An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation

Irritable Bowel Syndrome With Constipation | Chronic Idiopathic Constipation

United States
Bausch Health Americas, Inc.

Completed

The Plecanatide Irritable Bowel Syndrome With Constipation Study (IBS-C) (CIBS)

Irritable Bowel Syndrome Characterized by Constipation

United States
Astellas Pharma Inc

Completed

A Study to Evaluate Dose Responses of Efficacy and Safety of ASP0456 in Patient With Chronic Constipation

Chronic Constipation

Japan
Forest Laboratories

Completed

A Lactation Study in Women Who Are Breastfeeding or Pumping and Are Receiving Linaclotide Therapeutically (LIN-PK-01)

Irritable Bowel Syndrome | Constipation | Breast Feeding

United States
Bausch Health Americas, Inc.

Completed

Single Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PK) of SP-333 Tablets in Healthy Adult Subjects

Exposure

United States
Bausch Health Americas, Inc.
Parexel

Completed

The Plecanatide Chronic Idiopathic Constipation (CIC) Study

Chronic Idiopathic Constipation

United States
Ironwood Pharmaceuticals, Inc.
Forest Laboratories

Completed

Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

Irritable Bowel Syndrome With Constipation

United States

3

Subscribe